Stay updated with breaking news from Modified Vaccinia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Uganda Aids Commission says more than 50,000 Ugandans contract HIV every year, with around 17,000 HIV-related deaths among the estimated 1.4 million Ugandans living with HIV
<p style="text-align:justify">New research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows that the antibodies produced by Modified Vaccinia virus Ankara - Bavarian Nordic (MVA-BN) vaccination against mpox wane significantly within a year of receiving the vaccination – but in people with pre-existing immunity due to childhood smallpox vaccination in childhood, antibody levels remain high in almost all cases. The study is presented by PhD student Dr. Marc S...
/PRNewswire/ -- The "Viral & Non-Viral Vector Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027" report has been...
In a new study, researchers assessed the immunogenicity, safety, and booster-efficacy of the Modified Vaccinia virus Ankara-Bavarian Nordic (MVA-BN) vaccine currently being used for immunization against monkeypox.
Background Coronavirus disease 2019 (COVID-19) vaccination has substantially altered the course of the pandemic, saving tens of millions of lives globally. The problem is that despite such spectacular results, vaccination alone will not be able to control the COVID-19 pandemic because of the rapid evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) even in vaccinated human populations. Therefore, the development of a post-infection, broad-based, orally administered antiviral therapy that would complement vaccination efforts is urgently needed. Methodology The so-calle...